1ptw: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Cyclic nucleotide phosphodiesterases (PDEs) regulate the intracellular, concentrations of cyclic 3',5'-adenosine and guanosine monophosphates, (cAMP and cGMP, respectively) by hydrolyzing them to AMP and GMP, respectively. Family-selective inhibitors of PDEs have been studied for, treatment of various human diseases. However, the catalytic mechanism of, cyclic nucleotide hydrolysis by PDEs has remained unclear. We determined, the crystal structure of the human PDE4D2 catalytic domain in complex with, AMP at 2.4 A resolution. In this structure, two divalent metal ions, simultaneously interact with the phosphate group of AMP, implying a, binuclear catalysis. In addition, the structure suggested that a hydroxide, ion or a water bridging two metal ions may serve as the nucleophile for, the hydrolysis of the cAMP phosphodiester bond.
Cyclic nucleotide phosphodiesterases (PDEs) regulate the intracellular concentrations of cyclic 3',5'-adenosine and guanosine monophosphates (cAMP and cGMP, respectively) by hydrolyzing them to AMP and GMP, respectively. Family-selective inhibitors of PDEs have been studied for treatment of various human diseases. However, the catalytic mechanism of cyclic nucleotide hydrolysis by PDEs has remained unclear. We determined the crystal structure of the human PDE4D2 catalytic domain in complex with AMP at 2.4 A resolution. In this structure, two divalent metal ions simultaneously interact with the phosphate group of AMP, implying a binuclear catalysis. In addition, the structure suggested that a hydroxide ion or a water bridging two metal ions may serve as the nucleophile for the hydrolysis of the cAMP phosphodiester bond.


==Disease==
==Disease==
Line 26: Line 26:
[[Category: catalytic mechanism]]
[[Category: catalytic mechanism]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:41:36 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:32:30 2008''

Revision as of 15:32, 21 February 2008

File:1ptw.jpg


1ptw, resolution 2.3Å

Drag the structure with the mouse to rotate

The Crystal Structure of AMP-Bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysis

OverviewOverview

Cyclic nucleotide phosphodiesterases (PDEs) regulate the intracellular concentrations of cyclic 3',5'-adenosine and guanosine monophosphates (cAMP and cGMP, respectively) by hydrolyzing them to AMP and GMP, respectively. Family-selective inhibitors of PDEs have been studied for treatment of various human diseases. However, the catalytic mechanism of cyclic nucleotide hydrolysis by PDEs has remained unclear. We determined the crystal structure of the human PDE4D2 catalytic domain in complex with AMP at 2.4 A resolution. In this structure, two divalent metal ions simultaneously interact with the phosphate group of AMP, implying a binuclear catalysis. In addition, the structure suggested that a hydroxide ion or a water bridging two metal ions may serve as the nucleophile for the hydrolysis of the cAMP phosphodiester bond.

DiseaseDisease

Known disease associated with this structure: Stroke, susceptibility to, 1 OMIM:[600129]

About this StructureAbout this Structure

1PTW is a Single protein structure of sequence from Homo sapiens with and as ligands. Active as 3',5'-cyclic-nucleotide phosphodiesterase, with EC number 3.1.4.17 Full crystallographic information is available from OCA.

ReferenceReference

The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis., Huai Q, Colicelli J, Ke H, Biochemistry. 2003 Nov 18;42(45):13220-6. PMID:14609333

Page seeded by OCA on Thu Feb 21 14:32:30 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA